标题
Metronomic Chemotherapy for Metastatic Breast Cancer
作者
关键词
-
出版物
Oncology Research and Treatment
Volume 45, Issue 1-2, Pages 12-17
出版商
S. Karger AG
发表日期
2021-11-25
DOI
10.1159/000520236
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Safety and efficacy study of oral metronomic vinorelbine combined with trastuzumab (mNH) in HER2-positive metastatic breast cancer: a phase II trial
- (2021) Zijing Wang et al. BREAST CANCER RESEARCH AND TREATMENT
- Metronomic Chemotherapy
- (2021) Marina Elena Cazzaniga et al. Cancers
- Low-dose metronomic chemotherapy as an efficient treatment option in metastatic breast cancer—results of an exploratory case–control study
- (2020) S. Krajnak et al. BREAST CANCER RESEARCH AND TREATMENT
- Metronomic chemotherapy offsets HIFα induction upon maximum‐tolerated dose in metastatic cancers
- (2020) Luana Schito et al. EMBO Molecular Medicine
- 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)†
- (2020) F. Cardoso et al. ANNALS OF ONCOLOGY
- Metronomic oral chemotherapy with cyclophosphamide plus capecitabine combined with trastuzumab (HEX) as first line therapy of HER-2 positive advanced breast cancer: A phase II trial of the Gruppo Oncologico Italia Meridionale (GOIM)
- (2020) Laura Orlando et al. BREAST
- Metronomic treatment of vinorelbine with oral capecitabine is tolerable in the randomized Phase 2 study XeNa including patients with HER2 non-amplified metastatic breast cancer
- (2020) Anne Sofie Brems-Eskildsen et al. ACTA ONCOLOGICA
- Tumor endothelial cells as a potential target of metronomic chemotherapy
- (2019) Ji Yoon Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Breast cancer statistics, 2019
- (2019) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study
- (2019) M.E. Cazzaniga et al. BREAST
- Metronomic Chemotherapy for First-Line Treatment of Metastatic Triple-Negative Breast Cancer: A Phase II Trial
- (2018) Emilia Montagna et al. Breast Care
- Vinorelbine, cyclophosphamide and 5-FU effects on the circulating and intratumoural landscape of immune cells improve anti-PD-L1 efficacy in preclinical models of breast cancer and lymphoma
- (2018) Stefania Orecchioni et al. BRITISH JOURNAL OF CANCER
- Does metronomic chemotherapy induce tumor angiogenic dormancy? A review of available preclinical and clinical data
- (2018) Gianfranco Natale et al. CANCER LETTERS
- Phase I Trial of Veliparib, a Poly ADP Ribose Polymerase Inhibitor, Plus Metronomic Cyclophosphamide in Metastatic HER2-negative Breast Cancer
- (2018) Jesus Anampa et al. Clinical Breast Cancer
- Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group
- (2018) Hans Wildiers et al. LANCET ONCOLOGY
- Metronomic capecitabine combined with aromatase inhibitors for new chemoendocrine treatment of advanced breast cancer: a phase II clinical trial
- (2018) Jian-wei Li et al. BREAST CANCER RESEARCH AND TREATMENT
- Breast cancer
- (2017) Nadia Harbeck et al. LANCET
- Inhibition of tumor growth by cancer vaccine combined with metronomic chemotherapy and anti-PD-1 in a pre-clinical setting
- (2017) Annacarmen Petrizzo et al. Oncotarget
- SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial
- (2016) Christoph Rochlitz et al. BMC CANCER
- Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 study
- (2016) M. E. Cazzaniga et al. BREAST CANCER RESEARCH AND TREATMENT
- Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose Chemotherapy
- (2016) Y. Shaked et al. CANCER RESEARCH
- Randomized phase II trial of cyclophosphamide and the oral poly (ADP-ribose) polymerase inhibitor veliparib in patients with recurrent, advanced triple-negative breast cancer
- (2016) Shivaani Kummar et al. INVESTIGATIONAL NEW DRUGS
- Novel endogenous angiogenesis inhibitors and their therapeutic potential
- (2015) Nithya Rao et al. ACTA PHARMACOLOGICA SINICA
- Metronomic chemotherapy: An attractive alternative to maximum tolerated dose therapy that can activate anti-tumor immunity and minimize therapeutic resistance
- (2015) Irina Kareva et al. CANCER LETTERS
- Capecitabine metronomic chemotherapy inhibits the proliferation of gastric cancer cells through anti-angiogenesis
- (2015) FEI YUAN et al. ONCOLOGY REPORTS
- On and off Metronomic Oral Vinorelbine in Elderly Women with Advanced Breast Cancer
- (2015) Francesca De Iuliis et al. TUMORI
- On and off Metronomic Oral Vinorelbine in Elderly Women with Advanced Breast Cancer
- (2015) Francesca De Iuliis et al. TUMORI JOURNAL
- Tumour endothelial cells acquire drug resistance in a tumour microenvironment
- (2013) K. Hida et al. JOURNAL OF BIOCHEMISTRY
- Combination antiangiogenic therapy in advanced breast cancer: a phase 1 trial of vandetanib, a VEGFR inhibitor, and metronomic chemotherapy, with correlative platelet proteomics
- (2012) Erica L. Mayer et al. BREAST CANCER RESEARCH AND TREATMENT
- Metronomic Chemotherapy Combined With Bevacizumab and Erlotinib in Patients With Metastatic HER2-Negative Breast Cancer: Clinical and Biological Activity
- (2012) Emilia Montagna et al. Clinical Breast Cancer
- Cancer stem cells
- (2012) Zuoren Yu et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Exploratory predictive and prognostic factors in advanced breast cancer treated with metronomic chemotherapy
- (2011) Manuela Miscoria et al. ANTI-CANCER DRUGS
- Efficacy and safety of low-dose metronomic chemotherapy with capecitabine in heavily pretreated patients with metastatic breast cancer
- (2011) P. Fedele et al. EUROPEAN JOURNAL OF CANCER
- Metronomic gemcitabine suppresses tumour growth, improves perfusion and reduces hypoxia in human pancreatic ductal adenocarcinoma
- (2010) K K Y Cham et al. BRITISH JOURNAL OF CANCER
- Metronomic Cyclophosphamide and Capecitabine Combined With Bevacizumab in Advanced Breast Cancer
- (2008) Silvia Dellapasqua et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started